Huawei WATCH 4 Series Will Debut With Support For Hyperglycemia Risk Assessment

May 15, 2023

On May 15th, Gizcoupon reported that Huawei Yu Chengdong’s official Weibo account(Chinese Social Platform) announced that its smartwatch would be the first to support Hyperglycemia risk assessment research. The Huawei WATCH 4 series will be the first to support this feature. Users can opt to participate in the research project and wear the watch for a period of time. The watch will then inform them of their Hyperglycemia risk level, thereby encouraging them to pay further attention to their health and lifestyle. The Huawei WATCH 4 series will debut at Huawei’s new product launch on May 18th, Beijing time.

As shown on the poster, the product is not a medical device, and the measured data and results are for reference only and should not be used as a basis for diagnosis and treatment. The Hyperglycemia risk assessment feature requires users to participate in blood sugar health research initiated by third-party professional medical institutions. In addition, it is unsuitable for users under 18 years of age, those with type I diabetes, gestational diabetes, and other special types of diabetes. Using the picture as an example, a Hyperglycemia risk assessment can assess the type of risk within a week. For example, for medium risk, “there may be short-term fluctuations in blood sugar, and excessive intake of high-sugar, high-oil, and high-fat diets may increase the risk of Hyperglycemia.” Furthermore, users can also click the button to “start a new round of assessment.”

Previously, at a European launch event, Huawei unveiled its flagship smartwatch, the WATCH 4 series, as reported by Gizcoupon. The Huawei WATCH 4 Pro features a 48mm titanium case, a 1.5-inch LTPO AMOLED display with a sapphire glass cover, and a weight of 48 grams. In contrast, the Huawei WATCH 4 is slightly smaller, with a 46mm stainless steel case.

We will be happy to hear your thoughts

Leave a Reply

Register New Account